Clinical Trial Update: Phase II Trial of Sequential Consolidation With Pembrolizumab Followed by Nab-paclitaxel [Phase 2]

View source ↗

Summary

Phase II trial updates sequential consolidation with pembrolizumab followed by nab-paclitaxel in non-small cell lung cancer; study completed with posted results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Nab-paclitaxel (paclitaxel protein-bound)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2022-06-03